• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Regeneron

Anonymous board for Regeneron
Replies
92
Views
9K
anonymous
Replies
140
Views
51K
anonymous
Replies
0
Views
62
anonymous
Replies
1
Views
373
anonymous
Replies
17
Views
1K
anonymous
Replies
17
Views
1K
anonymous
Replies
7
Views
2K
anonymous
Replies
1
Views
350
anonymous
Replies
1
Views
237
anonymous
Replies
2
Views
2K
anonymous
Replies
5
Views
1K
anonymous
Replies
7
Views
1K
anonymous
Replies
8
Views
1K
anonymous
Replies
4
Views
624
anonymous
Replies
26
Views
4K
anonymous
Replies
33
Views
4K
anonymous
Replies
191
Views
16K
anonymous
Replies
0
Views
428
anonymous